Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04245904 Completed - Clinical trials for Physical Fitness, Basketball, Respiratory

Comparison of Respiratory Functions and Physical Fitness Parameters of Professional Basketball Players With Sedentary Controls

Start date: January 15, 2019
Phase:
Study type: Observational

The aim of the study was to compare the professional basketball players and sedentary controls in terms of respiratory function and physical fitness parameters and to investigate the relationship between respiratory function and physical fitness parameters in basketball players.

NCT ID: NCT04244890 Completed - Infant, Newborn Clinical Trials

Feasibility of Uninterrupted Infant Respiratory Support Treatment

FUIRST
Start date: February 21, 2020
Phase:
Study type: Observational

Feasibility study of a simplified respiratory support system for newborn infants

NCT ID: NCT04244786 Completed - Depression Clinical Trials

Treating Self Injurious Behavior: A Novel Brain Stimulation Approach

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the tolerability and effectiveness of transcranial direct current stimulation (tDCS) as a potential treatment for non-suicidal self-injury (NSSI). NSSI is the deliberate attempt to harm oneself, most often through cutting or burning, without suicidal intent. NSSI is a maladaptive emotion-regulation strategy often triggered by negative emotions, especially those involving feelings of rejection. tDCS is a low-cost, portable, well-tolerated, non-invasive form of brain stimulation that delivers a low current to a specific area of the brain via electrodes. Several studies have demonstrated its effectiveness in treating an array of conditions, depending on electrode placement, including depression and chronic pain. tDCS may also facilitate adaptive emotion regulation; researchers have also successfully used tDCS to reduce negative emotions and aggressive responses to social rejection. The investigators therefore seek to explore tDCS as a potential treatment for NSSI. This pilot feasibility study seeks 1) to examine how at-home, self-administered tDCS is tolerated in a sample of individuals who engage in frequent NSSI; 2) to gather pilot data regarding changes in emotional and neural responses during a social task after a series of tDCS sessions in this clinical population of individuals who engage in NSSI; 3) to gather pilot data on the effects of tDCS on NSSI behaviors and urges. The investigators seek to recruit a sample of 22 individuals who engage in frequent NSSI to complete all study procedures. Individuals will be randomized to receive active- or sham-tDCS for two twenty-minute applications on each of six alternating days over approximately two weeks. Participants will be trained on tDCS self-administration, which will be supervised during each session over a videoconferencing platform by a researcher. Functional MRI (fMRI) may be performed at baseline and again after the completion of 12 sessions of tDCS. Subjects' NSSI and urges to engage in NSSI will be recorded for four weeks in real-time, using an iPod- based system that reminds subjects to stop at certain times during the day to record their thoughts, feelings, and behaviors. This will allow measurement of NSSI urges and behaviors for one week before, two weeks during, and one week after the tDCS intervention. The long-term goal of this study is to identify a novel form of treatment for NSSI and to better understand NSSI pathophysiology.

NCT ID: NCT04244617 Completed - Mental Disorder Clinical Trials

Peer-supported Internet Mediated Psychological Treatment

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

This study evaluates the effect and experience of peer-support in internet mediated ACT (Acceptance and Commitment therapy) in an explorative pilot study with mixed method design conducted in primary care. Peer-supporters are certified support persons with personal experience of mental health problems and the process of rehabilitation, which becomes professionally active in care and support to patients in their recovery

NCT ID: NCT04244045 Completed - Clinical trials for Musculoskeletal Diseases or Conditions

Sub Occipital Muscle Inhibition Versus Slump Stretch Position in Short Hamstring Syndrome Subjects

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

45 female participants with short hamstring syndrome were devided into one of the three groups; Group I: suboccipital muscle inhinbition plus passive hamstring stretch, group II: Slump stretch position plus Passive hamstring stretch, and group III: Passive stretch of hamstring muscle. Assessment methods were Straight leg raising test, forward flexion test and popliteal angle test, were measured at baseline, immediately after 1st treatment session then after 4 weeks of treatment.

NCT ID: NCT04243122 Completed - Clinical trials for Primary Myelofibrosis

Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients

AIRPORT-MPN
Start date: February 17, 2021
Phase: Phase 2
Study type: Interventional

Myeloproliferative neoplasms (MPNs) are blood disorders that occur when the body makes too many white or red blood cells, or platelets. This overproduction of blood cells in the bone marrow can create problems for blood flow and lead to various symptoms. One of the major problems is the formation of blood clots. These may form in the veins of a patient's legs or arms where they cause leg or arm pain, swelling or difficulty walking. These clots may travel to the lung and then cause chest pain, shortness of breath and sometimes death. Blood clots can also lead to poor or no blood flow to one's heart, brain, or other organs, causing damages that cannot be easily or ever repaired, such as stroke or heart attack. Patients diagnosed with certain types of MPN are associated with a higher risk of developing blood clots and related complications. For this reason, MPN patients are usually treated with low-dose aspirin, a common drug used for blood clot prevention, on long-term basis to prevent the formation of blood clots and other complications. However, recent studies also show that the risk of blood clots remains elevated in MPN patients treated with aspirin, and there may not be improvement or reduction in fatal or other events that are associated with blood clots. In addition, since this medical condition is rare, so there's a lack of studies done with high quality results to help physicians decide the best treatment plan for these patients. The study drug, apixaban, is a new type of orally-taken blood thinner that has been shown to be effective and safe for prevention and treatment of blood clots in various patient populations. The investigators will evaluate whether apixaban is safer and/or better at preventing blood clots and other complications in MPN patients compared to aspirin.

NCT ID: NCT04242719 Completed - Clinical trials for Deep Retinal Capillary Ischemia

Management of Deep Retinal Capillary Ischemia by Electromagnetic Stimulation and Platelet- Rich Plasma

rEMS
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

To investigate the efficacy of retinal electromagnetic stimulation and sub-tenon autologous platelet rich plasma in the treatment of deep retinal capillary ischemia.

NCT ID: NCT04242485 Completed - Clinical trials for Cardiovascular Physiological Phenomena

Osteopathy Treatment and Cardiovascular Recovery After a Rugby Match

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study was to explore the efficacy of osteopathic manipulative treatment (OMT), a form of non-invasive manual treatment, for a faster recovery of cardiovascular parameters after a rugby union match in professional male athletes. To this end, the effects of OMT on resting cardiovascular function and cardiovascular reactivity were evaluated in twenty-three male players 18-20 hours after a match and compared with a corresponding no-match (control) condition. Assessment of resting cardiovascular parameters 18-20 hours after a match revealed the presence of elevated mean arterial pressure and heart rate, and reduced vagally-mediated heart rate variability compared with a no-match condition. OMT provoked a significant reduction in mean arterial pressure and increased vagally-mediated heart rate variability at rest both in the after match and control conditions. Moreover, OMT favoured a larger vagal withdrawal in response to an orthostatic stress compared with a sham treatment. These results suggest that OMT may be implemented as a recovery strategy to restore athletes' cardiovascular homeostasis after a rugby union match.

NCT ID: NCT04241926 Completed - Clinical trials for Hemodynamic Monitoring

Single-lumen 5Fr and Triple-lumen 6Fr PICCs Are Accurate for Hemodynamic Measurement by Transpulmonary Thermodilution.

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

Peripherally inserted central catheters (PICCs) are increasingly used in intensive care unit (ICU) as an alternative to centrally inserted central catheters (CICCs) for intravenous infusion. In the present study the investigators try to assess their reliability for measuring cardiac index (CI) with trans-pulmonary thermodilution (TPTD) technique.

NCT ID: NCT04241874 Completed - Clinical trials for Acute Respiratory Distress Syndrome

PEEP and Spontaneous Breathing During ARDS

EARDS
Start date: May 1, 2021
Phase: N/A
Study type: Interventional

Prospective, physiological study to systematically assess the effects of high positive end-expiratory pressure (PEEP) with and without inspiratory synchronization in patients with moderate to severe acute respiratory distress syndrome (ARDS) exhibiting intense inspiratory effort while on assisted ventilation.